Luye Pharma Group Ltd. announced the completion of the early redemption of all outstanding 6.25 per cent convertible bonds due 2028.

Key details: • Original issuance: US$180.00 million of 6.25 per cent convertible bonds, issued on 6 July 2023. • Bondholder option: Under Condition 8(E), investors could redeem their holdings at par plus accrued interest on 6 July 2026 (“Optional Put Date”). • Redemption size: Holders exercised the option for bonds totaling US$90.26 million in principal, representing 100 per cent of the outstanding amount. • Completion: As of 6 July 2026, Luye Pharma has fully redeemed and cancelled the bonds; no outstanding balance remains. • Listing status: The company has applied to The Stock Exchange of Hong Kong Limited to withdraw the bond listing, expected to take effect after market close on 15 July 2026.

The early redemption eliminates this tranche of debt from Luye Pharma’s balance sheet well ahead of the 2028 maturity, concluding the obligations associated with the instrument.